News

Godavari Biorefineries receives Japanese patent

16-Jun-2026 | 10:37
For a novel class of compounds used in treatment of Cancer

Godavari Biorefineries announced that the Japanese Patent Office has granted its patent, 5-HYDROXY 1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER,.

This patent covers a novel class of compounds that exhibit strong inhibitory effects on cancer and cancer stem cells, demonstrating significant efficacy against multiple types, including breast and prostate cancer.